Pharmacotherapy for Hyperglycemia in Noncritically Ill Hospitalized Patients
Authors:
- Carlos E. MendezCMCarlos E. Mendez
- Guillermo E. UmpierrezGUGuillermo E. Umpierrez
Open Access
- 1 August 2014
- journal article
- Published by American Diabetes Association in Diabetes Spectrum
- Vol. 27 (3) , 180-188
Abstract
In Brief Hyperglycemia in the hospital setting affects 38–46% of noncritically ill hospitalized patients. Evidence from observational studies indicates that inpatient hyperglycemia, in patients with and without diabetes, is associated with increased risks of complications and mortality. Substantial evidence indicates that correction of hyperglycemia through insulin administration reduces hospital complications and mortality in critically ill patients, as well as in general medicine and surgery patients. This article provides a review of the evidence on the different therapies available for hyperglycemia management in noncritically ill hospitalized patients.Keywords
This publication has 111 references indexed in Scilit:
- Metformin: an old but still the best treatment for type 2 diabetesDiabetology & Metabolic Syndrome, 2013
- Hypoglycemia-associated Mortality Is Not Drug-associated but Linked to ComorbiditiesThe American Journal of Medicine, 2011
- Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Events: A Meta-Analysis of Randomized Clinical TrialsExperimental Diabetes Research, 2011
- The effect of tight glycaemic control, during and after cardiac surgery, on patient mortality and morbidity: A systematic review and meta-analysisJournal of Cardiothoracic Surgery, 2011
- Hypoglycemia, Diabetes, and Cardiovascular EventsDiabetes Care, 2010
- Hyperglycemia–related mortality in critically ill patients varies with admission diagnosis*Critical Care Medicine, 2009
- American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic ControlDiabetes Care, 2009
- The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over studyCritical Care, 2009
- Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study dataCanadian Medical Association Journal, 2009
- Comparison of Inpatient Insulin Regimens with Detemir plus Aspart Versus Neutral Protamine Hagedorn plus Regular in Medical Patients with Type 2 DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2009